BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 16217074)

  • 1. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
    Valsasina P; Benedetti B; Rovaris M; Sormani MP; Comi G; Filippi M
    Neurology; 2005 Oct; 65(7):1126-8. PubMed ID: 16217074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland.
    Meijboom R; Wiseman SJ; York EN; Bastin ME; Valdés Hernández MDC; Thrippleton MJ; Mollison D; White N; Kampaite A; Ng Kee Kwong K; Rodriguez Gonzalez D; Job D; Weaver C; Kearns PKA; Connick P; Chandran S; Waldman AD
    Wellcome Open Res; 2022; 7():94. PubMed ID: 36865371
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
    Cagol A; Fuertes NC; Stoessel M; Barakovic M; Schaedelin S; D'Souza M; Würfel J; Brandt AU; Kappos L; Sprenger T; Naegelin Y; Kuhle J; Granziera C; Papadopoulou A
    J Neurol; 2023 Apr; 270(4):2139-2148. PubMed ID: 36625888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive MRI Biomarkers in MS-A Critical Review.
    Tiu VE; Enache I; Panea CA; Tiu C; Popescu BO
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334554
    [No Abstract]   [Full Text] [Related]  

  • 5. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
    Sastre-Garriga J; Pareto D; Battaglini M; Rocca MA; Ciccarelli O; Enzinger C; Wuerfel J; Sormani MP; Barkhof F; Yousry TA; De Stefano N; Tintoré M; Filippi M; Gasperini C; Kappos L; Río J; Frederiksen J; Palace J; Vrenken H; Montalban X; Rovira À;
    Nat Rev Neurol; 2020 Mar; 16(3):171-182. PubMed ID: 32094485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance Imaging.
    Andica C; Hagiwara A; Kamagata K; Yokoyama K; Shimoji K; Saito A; Takenaka Y; Nakazawa M; Hori M; Cohen-Adad J; Takemura MY; Hattori N; Aoki S
    Sci Rep; 2019 May; 9(1):8147. PubMed ID: 31148572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
    MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
    Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
    MacKenzie-Graham A; Kurth F; Itoh Y; Wang HJ; Montag MJ; Elashoff R; Voskuhl RR
    JAMA Neurol; 2016 Aug; 73(8):944-53. PubMed ID: 27294295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic imaging review: Multiple Sclerosis.
    Katdare A; Ursekar M
    Ann Indian Acad Neurol; 2015 Sep; 18(Suppl 1):S24-9. PubMed ID: 26538845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
    Ligocki AJ; Rivas JR; Rounds WH; Guzman AA; Li M; Spadaro M; Lahey L; Chen D; Henson PM; Graves D; Greenberg BM; Frohman EM; Ward ES; Robinson W; Meinl E; White CL; Stowe AM; Monson NL
    ASN Neuro; 2015; 7(5):. PubMed ID: 26489686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
    Newbould RD; Nicholas R; Thomas CL; Quest R; Lee JS; Honeyfield L; Colasanti A; Malik O; Mattoscio M; Matthews PM; Sormani MP; Waldman AD; Muraro PA
    Neuroimage Clin; 2014; 4():641-8. PubMed ID: 24936415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
    Syc SB; Harrison DM; Saidha S; Seigo M; Calabresi PA; Reich DS
    Mult Scler Int; 2013; 2013():838719. PubMed ID: 23476776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.
    Zivadinov R; Tekwe C; Bergsland N; Dolezal O; Havrdova E; Krasensky J; Dwyer MG; Seidl Z; Ramasamy DP; Vaneckova M; Horakova D
    Mult Scler Int; 2013; 2013():231345. PubMed ID: 23365753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
    Kirov II; Tal A; Babb JS; Herbert J; Gonen O
    Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
    Shiee N; Bazin PL; Zackowski KM; Farrell SK; Harrison DM; Newsome SD; Ratchford JN; Caffo BS; Calabresi PA; Pham DL; Reich DS
    PLoS One; 2012; 7(5):e37049. PubMed ID: 22615886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of grey matter pathology in multiple sclerosis.
    Horakova D; Kalincik T; Dusankova JB; Dolezal O
    BMC Neurol; 2012 Mar; 12():10. PubMed ID: 22397707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI pattern recognition in multiple sclerosis normal-appearing brain areas.
    Weygandt M; Hackmack K; Pfüller C; Bellmann-Strobl J; Paul F; Zipp F; Haynes JD
    PLoS One; 2011; 6(6):e21138. PubMed ID: 21695053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis.
    Furby J; Hayton T; Altmann D; Brenner R; Chataway J; Smith KJ; Miller DH; Kapoor R
    J Neurol; 2010 Sep; 257(9):1508-16. PubMed ID: 20437181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosum index and long-term disability in multiple sclerosis patients.
    Yaldizli O; Atefy R; Gass A; Sturm D; Glassl S; Tettenborn B; Putzki N
    J Neurol; 2010 Aug; 257(8):1256-64. PubMed ID: 20198382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.
    Filippi M; Rocca MA
    AJNR Am J Neuroradiol; 2010 Aug; 31(7):1171-7. PubMed ID: 20044503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.